Category: Health News

Let’s Talk Shit

Let’s Talk Sh!t

Let’s Talk Shit Disease, Digestion & Fecal Transplants

Let’s Talk Sh!t is a humorous, easy to digest explanation of gastrointestinal disorders, their current treatments, as well as next generation hope for heart disease, obesity, autism, Alzheimer’s, and more. From constipation to cancer, research indicates that our unique microbiomes may be the basis for future advances in health and wellness.

Let’s Talk Sh!t examines the human microbiome—the  dynamic world of bacteria, fungus, and viruses that comprises more than 50% of our mortal selves.

Dr. Sabine Hazan and Dr. Thomas Borody, leaders in microbiome research, explore the reason therapies may not be working for many and why fecal transplants may be part of the solution. They also share nutritional tips to avoid illness, improve digestion, and support our own microbiomes.

About the Authors

Sabine Hazan

lets talk shit, Sabine Hazan

Sabine Hazan was the first of four children born to two government accountants in Morocco. In 1974 the family moved to Montreal, Canada to provide better education and greater opportunities. There, the Hazans raised their children with the ambition to match their potential—all became doctors.  

Throughout her life, Sabine’s peers questioned her dream to become a physician. But their challenges only fueled her ambitions. Even though her primary language was French, she enrolled in Concordia University, an English-speaking college.

Medical school admittance was difficult and more so for a woman. Sabine was asked: What if you become pregnant? What would you do if your child was sick and you also had a sick patient needing care? Whom would you choose? She wondered how many men were asked such questions.

She graduated from Dalhousie Medical School in Halifax, Nova Scotia. Curious about the American health care system, she chose to do her residency in Internal Medicine at Jackson Memorial Hospital, a notoriously demanding and rigorous county hospital in Miami. There, during the height of the HIV/AIDS crisis, she was under fire, learning to care for the most underserved patients who were desperately ill and dying. She fell further in love with medicine and with a fellow resident whom she married in 1993.

During her early medical career, she was keenly interested in gastroenterology. “It’s a man’s specialty,” she was told repeatedly. She would never be accepted. The naysayers again had the opposite effect and emboldened her resolve. In 1995, She became the first female Gastroenterology Fellow accepted at the University of Florida in Jacksonville. As a fellow, she discovered that she really enjoyed and excelled in clinical research, which led to awards from the university’s Dean for Research as well as recognition from the American College of Physicians. At the time, her primary research was in esophageal diseases, part of her work with her formidable mentor, Dr. Sami Achem. Her husband, Dr. Alon Steinberg, completed his Cardiology Fellowship at the same time and the couple had their first daughter in 1996.

Following her fellowship, Dr. Hazan returned to Montreal and opened a practice across the border in Upstate New York. Her enviable reputation grew quickly and due to socialized medicine in Canada, long wait lists for procedures like colonoscopies brought in many Canadian patients in need of gastroenterology care.

Just as Apple and Tesla were visionaries of technology, Dr. Hazan pursued innovation in medicine. Some perceived her as a threat. A perfectionist in her scientific approach and focused in her quest for excellence, the multi-tasking Hazan was never one for bureaucracy and red tape. She was reported to the medical board, cited for poor record keeping and required to take a course. The experience changed her. She became a warrior who vowed to extend her methodical approach in medical care to its documentation. In the ensuing years she emphasized extreme attention to detail, not just in her work product, but in her clinical research and records. She now embraces oversight from the Food and Drug Administration (FDA) and Independent Review Board (IRB). Her clinical trials are known for their validation and verification.

After the couple’s second daughter was born in 2004, Dr. Hazan rediscovered her passion for research and launched Ventura Clinical Trials. In 2005, she and her husband established respective patient practices in Ventura. Over the years, she attended several national GI conferences where she often met with her good friend and colleague, Dr. Neil Stollman, also a Gastroenterology Fellow in Miami during their residency years. Dr. Stollman had introduced her to the world of fecal microbiota transplant (FMT) and research by Dr. Thomas Borody since the late ‘90s.

Dr. Hazan started researching the use of FMT to treat patients with C. diff, which changed the trajectory of her career. It was Dr. Stollman’s explorations that inspired her to consider the human digestive tract as the body’s Garden of Eden. She later met Dr. Thomas Borody, the father of modern FMT. The meeting proved to be the beginning of a great collaborative relationship that continues to this day as they work together on advanced clinical research of the microbiome. 

After hundreds of clinical trials and treating thousands of patients, Dr. Hazan still faced persistent questions about life, death, health, illness, the gut, and how they were connected. Various curiosities, innovative concepts and ruminations kept her awake at night. Why did she crave McDonald’s when she was pregnant the first time? Why does her first daughter still love it? Alternatively, why does her youngest love vegetables, which Sabine craved often during her second pregnancy? Through research, she saw how dramatically the microbiome impacted human health, and she grew increasingly determined to understand.

Her curiosity led her to Dr. Sydney Finegold at UCLA. Dr. Finegold was certain of an association between bacteria, bowels, and behavior. He was especially sure of a connection between anaerobic bacteria and autism. If bacteria could contribute to autistic behavior, Dr. Hazan wondered if other tendencies, preferences, and characteristics could also be consequences of one’s microbiome.

Could she study the bacteria in human feces and isolate it for treatment? Could she continue trailblazing through an emerging science? When preliminary research of the microbiome led to fecal material in capsules, with venture capitalists controlling the stocks of sh!t, one could say she went rogue. Strongly opposed to a “one pill fits all” solution, she felt called to pioneer her own microbiome research at the clinical level. She was determined to develop valid reproducible data and to leverage that data to emphasize the importance of individualized treatment for patients.

Resolute, she launched ProgenaBiome, a genetic sequencing research company dedicated to understanding the gut flora at the clinical level to advance FMT and other microbial-based therapies. As her professional network grew, she realized that doctors and researchers worldwide were asking the same questions. She traveled, addressed medical forums, and wrote articles in her quest for answers. Meanwhile, she worked persistently to help patients with celiac disease, Crohn’s, ulcers, colitis, and other digestive ailments that she hypothesized were caused by dysbiosis in the gut.

Dr. Sabine Hazan’s quest continues. She and Dr. Borody believe that answers to many medical mysteries and the power to heal may be within the trillions of microbes in the gut flora. Answers are close.

Sheli Ellsworth

Science junkie Sheli Ellsworth grew up on a small farm in Texas and has seen both ends of the life cycle. She graduated magna cum laude from Texas Woman’s University and obtained her master’s degree from West Texas A&M with concentrations in psychology and biology.

After three cases of food poisoning, a son who licked the floor to gross out his sister, and a poop-eating pug—she too had questions about bacteria, behavior, and why she continues ordering chicken enchiladas.

A humorist at heart, this is her seventh book. If you enjoy Sheli’s writing, Confessions of a Pet Au Pair, an amusing guide to pet health is available on Amazon.

Thomas Borody

Microbiome pioneer Thomas Borody was born in Krakow, Poland. His father, Jan Borody, fought in the defense of Warsaw during the Nazi invasion of 1939, and then his parents then survived the German occupation of Poland. Jan, a pastor, worked as a double agent for the Polish underground while his photographer mother, Danuta, fed children trying to escape via sewage pipes from the ghetto.

His father found a way to take young Jewish girls out of ghettos and relocate them to the Krakow Carmelite nunnery where they could ultimately walk in groups over mountains to Switzerland and freedom. In Dec 1959, the family emigrated to Australia and settled in Sydney, where all three Borody children completed their Medical training. Edith became a family physician, Ian an obstetrician/ gynecologist, and Tom a gastroenterologist.

He completed his BS and MB BS degrees at the University of New South Wales then received his MD from Garvan Institute of Medical Research and University of Sydney School of Veterinary Science. He gained experience in parasitology, the treatment of TB and leprosy in the Solomon Islands then spent three years in clinical research at the Mayo Clinic, Rochester, MN. Later he earned a PhD at the University of Newcastle and his DSc at University of Technology Sydney.

Dr. Borody’s clinical interests focus on the development of novel treatments including those of human gut microbiome using fecal microbiota transplantation (FMT) to treat C. difficile infection, colitis, irritable bowel syndrome as well as neurologic and autoimmune disorders. In 1984, Dr. Borody established the Centre for Digestive Diseases (CDD) in Sydney, Australia and has overseen its growth into an active clinical research institute with 69 employees and 12 physicians treating around 10,000 patients per year. To date, Dr. Borody’s clinic has completed some 35,000 FMT treatments. He refined FMT by developing lyophilized (freeze-dried) FMT capsules and has published more than 310 research papers and has filed over 170 patents. His first FMT in 1988 was carried out on a patient with colitis who remained symptom free.

In 1985, he developed the first effective triple antibiotic therapy for H. pylori, which had a profound impact on curing hundreds of patients. The medication, was sold in the US as Helidac.

He later licensed quadruple antibiotic therapy now marketed as Pylera. He also developed the next generation, FDA-approved treatment for resistant H. pylori, Talicia.

Dr. Borody has also developed a Crohn’s disease treatment now in pivotal trials, as well as colonoscopy bowel prep products Glycoprep, Glycoprep C, Moviprep, and a capsule prep licensed to Salix.

Future Borody therapies include asthma-reversing treatment and a product to treat coronary heart disease as chronic infection. He is currently focusing on the eradication of coronavirus using repurposed, combined anti-viral therapy.

The microbiome

fecal transplant

best microbiome book

the best book on fecal transplant

 

physiotherapy near me – Sunshine Physiotherapy Cochrane

physiotherapy near me

Serving the physiotherapy needs of our Cochrane, Calgary and area communities. Sunshine Physiotherapy and Sport Rehabilitation is a highly specialized team of physiotherapy professionals with extensive post graduate education that allows us to best deliver our physiotherapy and rehabilitation assessments/programs in 45-minute appointments. We offer the highest quality physiotherapy, acupuncture, C.Gunn IMS and sports rehabilitation services as well as massage therapy.

B.Sc.PT, B.Sc.P.E., M.C.P.A., Clinic Owner, Physical Therapist, Diploma in Sport Physical Therapy, Kinesiologist, Massage Therapist, Post Graduate Certificates in Orthopedics, Medical Acupuncture, GUNN IMS, Women’s Health, Core Teacher, International Federation of Sport Physical Therapy

Denise knew she wanted to be a physiotherapist since high school. She has been passionate about her career ever since.

She believes that the patient is best served through collaboration with sports medicine doctors, orthopedic surgeons, family doctors and other allied health providers.

She obtained her combined physical therapy/physical education degrees from the University of Saskatchewan in 1996/1997. Denise worked in Saskatoon and then in Calgary at the Lindsay Park/Talisman Centre where she treated recreational athletes, National athletes and Pro athletes. At Sunshine Physio she continues to treat this array of athletes.

Denise has also worked in the school setting with children with disabilities and paediatrics offering early intervention and treatment. She no longer goes into the school setting, however routinely treats babies for tortocollis (head shape deformities) and paediatric neuromuscular issues.

The majority of her early career was in the sports setting. This included working with local, National and International teams. The highlight of those experiences was traveling as the team physio for the Canadian Men’s Rugby Team to Ireland.

Denise has taken her levels and competency exams in Orthopaedics. She has passed the oral and written component of the Manual and Manipulative therapy (Part A) from the Canadian Academy of Manipulative Therapy.

Denise has been involved in pursuing a level of excellence for her dear patients. In 1996, she obtained her Advanced Massage Therapy, in 1997 achieved her Personal Fitness and Lifestyle consultant, and in 2010 received her Diploma in Sports Physical Therapy. The diploma in sport medicine is the highest level awarded. This takes years of studying, course work and hands on work. She obtained perfect marks: presently there are a little over 100 physiotherapists across Canada with this level of distinction. She maintains this distinguished designation with continued required course and field work.

Denise suffered from a persistent, nagging pain for a couple of years in her right ovary. She found tremendous relief from Traditional Chinese Medicine, so in 2000 went to the University of Alberta to receive that designation from the renowned Dr. Steven Aung. In 2007 she took further courses in the use of acupuncture needles and obtained GUNN IMS (Intramuscular Stimulation).

After the birth of two large babies (10 pounds each), Denise took a variety of courses in women’s health to treat pelvic floor weakness, incontinence and pain (2004 – 2014). She has taken numerous courses to help females stay active and prevent pelvic floor issues such as incontinence and prolapses. She has expanded that knowledge to help men as well who have issues with prostate cancer and pelvic floor pain (2014).

In 2010 Denise was in a massive head on collision on the highway where she suffered numerous injuries, including fracturing (breaking) her back, foot, numerous torn ligaments, and suffering a serious concussion. She loves treating chronic pain of the spine. She has successfully returned to an active lifestyle through excellent physio, sports medicine and yoga. She loves working with a multidisciplinary team like she had, to provide an appropriate solution to ongoing musculoskeletal problems, which may involve providing referral for prolotherapy evaluation/treatment, or interventional radiology procedures; as well as providing physiotherapy management before, during and after such procedures. As well, she firmly believes in an active home exercise program or coming to her numerous classes that she offers if more guidance is needed or to ensure doing the exercises in a safe manner.

She has developed a personal interest in treatment of concussions and has taken numerous courses in the evaluation and treatment of concussions over her entire career. As research and treatment has changed dramatically over the course of her career, she continues to take courses to stay on the leading edge of what is new to help her dear patients.

She shares her passion for physio, sports medicine, energy medicine and yoga at the clinic and through the numerous classes she offers. The Core Yoga classes are designed to bridge the gap between physio treatments and to return to an active, pain free lifestyle. She has been teaching classes on and off for over 30 years, changing and enhancing them as she develops as a student and teacher. See her yoga bio and class info for more information.

best physiotherapy cochrane

physiotherapy cochrane

physio cochrane

physiotherapy near me

C.DIFF BREAKTHROUGH: Genetic Lab to Share Gut Microbiome Discovery

C.DIFF BREAKTHROUGH: Genetic Lab to Share Gut Microbiome Discovery
Progenabiome, a genetic sequencing laboratory of the gut flora. Leading the way into the FUTURE by understanding the microbiome NOW. The quest for a new healthcare revolution!
Progenabiome, a genetic sequencing laboratory of the gut flora. Leading the way into the FUTURE by understanding the microbiome NOW. The quest for a new healthcare revolution!

“This data will change healthcare and make us more aware of our gut microbiome,” said Dr. Sabine Hazan-Steinberg, CEO and Founder of Progenabiome. “2500 years later, we’re proving Hippocrates right…everything starts in the gut.”

Dr. Hazan, a Malibu-based gastroenterologist, has 20+ years experience leading clinical trials, many for C.diff. When trials failed, she used fecal microbiota transplant (FMT), following advice from friend Dr. Neil Stollman, gastroenterologist at UCSF and East Bay Center for Digestive Health. She also followed great work by Dr. Thomas Borody, FMT pioneer and Centre for Digestive Diseases founder. Success post-FMT for recurrent C.diff suggested the microbiome holds many answers.

Knowing the C.diff microbe has existed for 10 million years, she questioned why it now takes 50,000 lives annually.

Dr. Sydney Finegold, infectious disease specialist who researched Autism/microbiome for 50 years, recommended she acquire a next-generation sequencer. When he passed in 2018, his books went to Hazan, hoping she could continue his legacy.

In January, she joined pathologist Dr. Brad Barrows and scientific director Dr. Andreas Papoutsis to launch Progenabiome. Their first run found non-toxigenic C.diff in every sample, including those not diagnosed with the disease. Preliminary data shows the C.diff microbe is not transmitted hand-to-mouth as previously believed. It is already in the gut and becomes toxic when something ingested triggers it.

Progenabiome will present this groundbreaking discovery at ACG 2019 (Poster 1027 / Booth 1931) and the 7th Annual International C.diff Conference November 6-7, 2019 in St. Louis.

Progenabiome is investigating the role of the gut flora in various diseases through 11 studies overlooked by New England IRB. Progenabiome’s Mission: to better understand, prevent, and treat diseases by analyzing specific genetic codes of 40 trillion gut microbes. Dr. Hazan believes the art of Medicine lies in our ability to see outside the box and recognize that all microbes and humans are unique.

For more: progenabiome.com / Twitter / Facebook / LinkedIn

Contact: Stephanie Davis, marketing@progenabiome.com

the microbiome
the microbiome diet
the human microbiome
the gut microbiome
the human gut
the gut microbiota

Cision

Dr. Sabine Hazan & ProgenaBiome

Dr. Sabine Hazan & ProgenaBiome

Dr. Sabine Hazan, Our Start!

Born in Morocco, Dr. Sabine Hazan has always been dedicated to understanding life. She sought a career in medicine and was accepted to medical school based on outstanding research on obesity conducted as an undergraduate. She completed her residency at the University of Miami during the peak of the HIV epidemic, treating extremely ill patients at Jackson Memorial Hospital and in the local jail. There, she was awarded two prizes for her research. After completing her residency, Dr. Hazan became the first woman gastroenterology fellow at the University of Florida. There, she completed a year of research and presented her findings in poster format at the American College of Gastroenterology (ACG) National Meeting. It was at that moment that she was approached by the esteemed Dr. Neil Stollman. He told her that the future of medicine lies in the microbiome. For her exceptional work with visceral hyperalgesia she was awarded the Dean’s Research Award. Dr. Stollman is now an expert and leader on fecal transplant and Clostridioidesdifficile (C.diff) and serves on the governing board of the ACG.

Following her fellowship, Dr. Hazan returned to Montreal and opened a practice in upstate New York. Her work there consisted of 10 percent research and 90 percent private gastroenterology patients and brought many patients from across the border in Canada. She was the only female gastroenterologist in an 80-mile radius, and the influx of Canadian patients brought to light for her the problems with socialized medicine in Canada. These patients faced intolerable wait times for a visit with a gastroenterologist in Canada, and so visited Dr. Hazan in New York. After meeting with the Prime Minister of Health, Dr. Hazan helped bring about a dual system in Canada, in which private practices co-exist with socialized medicine. Her years of practice as a solo woman gastroenterologist brought her under the microscope on numerous occasions, facing scrutiny not encountered by her male colleagues. 

After the birth of her two children, Dr. Hazan and her husband Dr. Alon Steinberg moved to California. There, she joined her sister, Dr. Lydie Hazan, at Axis Today Clinical Trials as a Sub-Investigator, and began doing clinical trial research in California for the company in Beverly Hills. She also joined a medical group as a private practitioner in Ventura. However, her desire for innovation led her to establish thriving private practices in Malibu, Thousand Oaks, and Ventura. Still desiring to understand life, she started her own clinical trial company 16 years ago, Ventura Clinical Trials, and has been Principal Investigator and Sub Investigator in over 150 clinical trials. Many of these trials were for Clostridioides difficile infection (CDI), enough that through her impressive recruitment she became known as the Queen of C. difficile in the clinical trial community. When her patients with C.diff did not respond to traditional or clinical trial therapies, she resorted to treatment with fecal microbiota transplant. 

During her extensive clinical trial experience, Dr. Hazan observed how dramatically the microbiome can impact human health. Over the years, she followed the wise words of Dr. Stollman and explored the path of FMT. She observed that FMT has the power to cure more than C.diff infection, as she saw patients with Crohn’s, psoriasis, Alzheimer’s, and even cancer improve following transplant. Naturally, this dedicated scientist wanted to better understand the mechanism behind what she was seeing in her patients. She conducted extensive research, which led her to Dr. Sydney Finegold, an infectious disease specialist, who was also focused on the microbiome and its relationship to disease, particularly Autism. He told her that the answer lies in the bacteria of the gut, and that sequencing the microbiome to identify those bacteria was the answer. He advised her to acquire a next-generation sequencer and conduct studies using whole-genome shotgun sequencing to examine the mysteries of the microbiome.

As her clinical trial work continued, Dr. Hazan found that Fecal Microbiota Transplantation (FMT) was increasingly juxtaposed to her studies. While being a top recruiter for studies, she also treated two Crohn’s patients who developed CDI and required FMT. As the patients experienced symptom relief post-FMT,  Dr. Hazan discovered that FMT allowed her to improve their Crohn’s and restore the balance of their microbiome. Wanting to better understand how this was possible, she reached out to Dr. Thomas Borody, a pioneer researcher and father of modern FMT in the 1980s. 1984 Borody established the Centre for Digestive Diseases (CDD) in Sydney, Australia and has overseen its growth into an active clinical research institute with 65 employees. In 1985, Borody pioneered the first effective triple antibiotic therapy for Helicobater pylori, which had a profound impact on curing  hundreds of patients of their peptic ulcers. His clinic has completed close to 30,000 FMT treatments, and he has filed over 165 patents. The meeting between Dr. Borody and Dr. Hazan proved to be the beginning of a great collaborative relationship.

While the Woolsey fire ravaged southern California, Dr. Hazan received a call from the family of Dr. Finegold, to inform her that she would receive all his papers and books in hopes to continue his work on Autism. Continuing his legacy, she established a new company, ProgenaBiome™,  in January 2019 to investigate the microbiome. ProgenaBiome™ is a state-of-the-art genetic research sequencing laboratory with next-generation whole genome shotgun sequencing capabilities on-site as per Dr. Sydney Finegold’s recommendations. To run this incredible laboratory, Dr. Hazan brought on board Dr. Andreas Papoutsis, a brilliant scientist with extensive experience in assay development and next-generation sequencing. He researched and investigated new technologies for the analysis of BRCA-1, one of the genes associated with breast cancer, CART-19, a therapy for blood cancers, and T-cell receptors. Under his directorship the lab has officially launched with efficient workflow and meticulous processing. 

Through her groundbreaking work, Dr. Hazan has earned the respect and admiration of her colleagues, many of whom have joined her in the quest for a healthcare revolution and helped her create the Malibu MIcrobiome Meeting. While she is working to bring medicine to new frontiers, she believes there will always be a place for pharmaceutical clinical trials, naturopaths, nutritionists, and additional work on the microbiome. She believes that the answers will come not through competition, but rather through collaboration by all fields. Just as the post office still exists, decades after the development of e-mail, better understanding of the microbiome does not eliminate the need for other facets of medicine. She also believes in patient choice; that patients should be able to choose quality of life over quantity if they so desire and have the right to try any treatment of their choosing.

Dr. Hazan has been invited to speak all over the world, including at the Microbiome Congress and NIST. She is working with both to ensure that data generated by ProgenaBiome™ is valid, verified, and reproducible, which she believes can only be achieved through ethical research.

Dr. Hazan is a firm believer that disease can only be understood through precision medicine by focusing on the individual and the changes within. Much like each person has unique fingerprints, no two people have the same microbiome. She also believes in the importance of assessing disease by looking at family. Her overall goal is to understand the microbes that allow us to function, from those we are born with to those that will decompose us when we die. She hopes that her quest for individual microbiome understanding leads to an awareness we are simply a diverse collection of microbes, working together to shape the world.

For more: progenabiome.com / Twitter / Facebook / LinkedIn

Contact: Stephanie Davis, marketing@progenabiome.com

This will change healthcare and make us more aware of our gut microbiome

Dr. Sabine Hazan-Steinberg and the the microbiome

This data will change healthcare and make us more aware of our gut microbiome

Progenabiome, a physician-owned genetic sequencing laboratory, found cutting-edge data on Clostridium difficile (C.diff), a disease burdening 500,000+ Americans yearly. They will present a validated, verified, and reproduced C.diff Assay at The American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting on Monday, Oct. 28, 2019 in San Antonio.

Progenabiome, a genetic sequencing laboratory of the gut flora. Leading the way into the FUTURE by understanding the microbiome NOW. The quest for a new healthcare revolution!
Progenabiome, a genetic sequencing laboratory of the gut flora. Leading the way into the FUTURE by understanding the microbiome NOW. The quest for a new healthcare revolution!

“This data will change healthcare and make us more aware of our gut microbiome,” said Dr. Sabine Hazan-Steinberg, CEO and Founder of Progenabiome. “2500 years later, we’re proving Hippocrates right…everything starts in the gut.”

Dr. Hazan, a Malibu-based gastroenterologist, has 20+ years experience leading clinical trials, many for C.diff. When trials failed, she used fecal microbiota transplant (FMT), following advice from friend Dr. Neil Stollman, gastroenterologist at UCSF and East Bay Center for Digestive Health. She also followed great work by Dr. Thomas Borody, FMT pioneer and Centre for Digestive Diseases founder. Success post-FMT for recurrent C.diff suggested the microbiome holds many answers.

Knowing the C.diff microbe has existed for 10 million years, she questioned why it now takes 50,000 lives annually.

Dr. Sydney Finegold, infectious disease specialist who researched Autism/microbiome for 50 years, recommended she acquire a next-generation sequencer. When he passed in 2018, his books went to Hazan, hoping she could continue his legacy.

In January, she joined pathologist Dr. Brad Barrows and scientific director Dr. Andreas Papoutsis to launch Progenabiome. Their first run found non-toxigenic C.diff in every sample, including those not diagnosed with the disease. Preliminary data shows the C.diff microbe is not transmitted hand-to-mouth as previously believed. It is already in the gut and becomes toxic when something ingested triggers it.

Progenabiome will present this groundbreaking discovery at ACG 2019 (Poster 1027 / Booth 1931) and the 7th Annual International C.diff Conference November 6-7, 2019 in St. Louis.

Progenabiome is investigating the role of the gut flora in various diseases through 11 studies overlooked by New England IRB. Progenabiome’s Mission: to better understand, prevent, and treat diseases by analyzing specific genetic codes of 40 trillion gut microbes. Dr. Hazan believes the art of Medicine lies in our ability to see outside the box and recognize that all microbes and humans are unique.

For more: progenabiome.com / Twitter / Facebook / LinkedIn

Contact: Stephanie Davis, marketing@progenabiome.com

Dr Sabine Hazan from Progenabiome on Her Startup Company as well as clinical research

ProgenaBiome™

  • A genetic research lab whose interest is to understand the clinical implications of the microbiome. Our broad array of specialties allows us to look beyond fecal transplant to examine other fields of medicine in which dysbiosis could be the culprit of disease.
  • In collaboration with leading physicians in multiple specialties, spearheads the movement of validating, verifying, and clinically applying its sequencing data, to better understand the microbiome.

We are taking the microbiome to the clinical level to better understand disease, so that it may be better treated and prevented. 

Understands

ProgenaBiome™ understands that everyone is different and each person has their own unique microbiome.

Provides

ProgenaBiome™ provides DNA testing and microbiome testing to empower you to seek better health

Believes

ProgenaBiome™ believes that in order to find the best donor for fecal transplant, you must understand the microbiome of the donor.

Disclaimer – Protecting Your Privacy microbiome

ProgenaBiome™ does NOT sell your patients identifying data to pharmaceutical companies or anyone else. We are HIPAA Compliant. We are a physician-owned genetic research sequencing laboratory who work with regulatory bodies, FDA and Department of Health in hopes to understand the microbiome.

 

As found on Youtube

The Microbiome